Nephron Pharmaceuticals Corporation | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Nephron Pharmaceuticals Corporation
FDA

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

pharmacompass-1-m-2026-01-12

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

Contact Supplier

pharmacompass-2-m-2025-11-03

Nephron Pharmaceuticals Corporation

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 42 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
42 News #PharmaBuzz

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 18 FDA Orange Book

18 FDF Dossiers
18 FDA Orange Book

INSPECTIONS & REGISTRATIONS

26 FDA, 1 EDQM, 1 GDUFA

26 FDA
1 EDQM
1 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

26 All

01 3Nephron Pharmaceuticals Corp.

02 23Nephron Sc Inc

filter District Decision Reset all filters

26 All

01 6No Action Indicated

02 9Official Action Indicated

03 11Voluntary Action Indicated

filter Inspection End Date Reset all filters

26 All

01 12024-02-09

02 22022-04-20

03 12019-11-15

04 12019-06-07

05 12018-11-14

06 12018-04-20

07 12017-04-21

08 12017-01-20

09 12016-12-09

10 12016-07-06

11 12015-08-14

12 12015-03-12

13 12014-11-13

14 52014-02-21

15 32012-08-17

16 22011-06-17

17 22010-05-18

filter City Reset all filters

26 All

01 3Orlando

02 23West Columbia

filter Country/Area Reset all filters

26 All

01 26U.S.A

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Official Action Indicated

Inspection End Date : 2024-02-09

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Official Action Indicated

Inspection End Date : 2024-02-09

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Official Action Indicated

Inspection End Date : 2022-04-20

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Official Action Indicated

Inspection End Date : 2022-04-20

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Official Action Indicated

Inspection End Date : 2022-04-20

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Official Action Indicated

Inspection End Date : 2022-04-20

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-11-15

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-11-15

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

05

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2019-06-07

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2019-06-07

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

06

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2018-11-14

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2018-11-14

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

07

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2018-04-20

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2018-04-20

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

08

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-04-21

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-04-21

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

09

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-01-20

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-01-20

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

10

FDA Audited

USA

PharmaSynergy

Not Confirmed

FDA Audited

USA

PharmaSynergy

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2016-12-09

Nephron Pharmaceuticals Corporation

City : West Columbia

State : South Carolina

Country/Area : U.S.A

Zip : 29172

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2016-12-09

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.